Σιούλης

SEARCH 

• “Comparative study of intraocular pressure measurements using a new

Pulsatile Ocular Blood Flow (POBF) system and Goldmann tonometry”.

-   “An Open Label Study of the Safety and Efficacy of Intravitreal ISIS 2922 in Acquired Immune Deficiency Syndrome (AIDS) Patients with Cytomegalovirus Retinitis”, Protocol ISIS 2922-CS7, sponsored by ISIS Pharmaceuticals.

-   “A Randomized, Controlled Comparison of the Safety and Efficacy of  RS-79070, an Oral Prodrug of Gavciclovir, vs. IV Ganciclovir as induction            Therapy for the Treatment of Newly Diagnosed Peripheral Cytomegalovirus       Retinitis”. Protocol WV 15376, sponsored by Rosche Bioscience.

• “A Randomized Comparison of Two Dosage Schedules of Intravitreal ISIS 

2922 for Patients with Advanced Cytomegalovirus Retinitis”. Protocol ISIS 2922 CS 9, sponsored by ISIS Pharmaceuticals.

-    “Ganciclovir-Cidofovir CMV Retinitis Trial”. Protocol GCCRT, NIH National Eye Institute Grant#EY 08057-10 to the Studies of the Ocular Complication   of  AIDS (SOCA) Study Group.

• “Protein Kinase C-Beta Inhibitor-Diabetic Macular Edema Study” Eli Lilly 

DMS.

• “Vitrase for Vitreous Hemorrhage Study” ACS.

-    “Studies of Ocular Complications of Aids” (SOCA), National Institutes of  Health/National Eye Institute Grant# EY 08057.

• A Phase III Randomized, Multicenter, Double-Masked, Placebo-Controlled, Parallel Group Study of Tin Ethyl Etiopurpurin (SnET2) Photodynamic Therapy in the Treatment of Subfoveal Choroidal Neovascularization Associated with Age-related Macular Degeneration. (Protocol SNET2-98EA001)

• Ανάπτυξη – βελτίωση προγράμματος (software) ηλεκτρονικού υπολογιστού, για μεταφορά  δεδομένων ( εγχρώμων φωτογραφιών βυθού, αγγειογραφειών) σε υψηλή ανάλυση και υπό συμπίεση για τηλε-οφθαλμολογία.

‍